145 related articles for article (PubMed ID: 14510180)
21. Proposal for a unified CCN nomenclature.
Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
[TBL] [Abstract][Full Text] [Related]
22. CYR61 (CCN1) is essential for placental development and vascular integrity.
Mo FE; Muntean AG; Chen CC; Stolz DB; Watkins SC; Lau LF
Mol Cell Biol; 2002 Dec; 22(24):8709-20. PubMed ID: 12446788
[TBL] [Abstract][Full Text] [Related]
23. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.
Ivkovic S; Yoon BS; Popoff SN; Safadi FF; Libuda DE; Stephenson RC; Daluiski A; Lyons KM
Development; 2003 Jun; 130(12):2779-91. PubMed ID: 12736220
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia.
Gellhaus A; Schmidt M; Dunk C; Lye SJ; Kimmig R; Winterhager E
Mol Hum Reprod; 2006 Jun; 12(6):389-99. PubMed ID: 16675545
[TBL] [Abstract][Full Text] [Related]
26. CCN proteins: multifunctional signalling regulators.
Perbal B
Lancet; 2004 Jan; 363(9402):62-4. PubMed ID: 14723997
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1.
Katsuki Y; Sakamoto K; Minamizato T; Makino H; Umezawa A; Ikeda MA; Perbal B; Amagasa T; Yamaguchi A; Katsube K
Biochem Biophys Res Commun; 2008 Apr; 368(3):808-14. PubMed ID: 18275847
[TBL] [Abstract][Full Text] [Related]
28. Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein.
de Winter P; Leoni P; Abraham D
Growth Factors; 2008 Apr; 26(2):80-91. PubMed ID: 18428027
[TBL] [Abstract][Full Text] [Related]
29. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis.
Shi-Wen X; Leask A; Abraham D
Cytokine Growth Factor Rev; 2008 Apr; 19(2):133-44. PubMed ID: 18358427
[TBL] [Abstract][Full Text] [Related]
30. NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival.
Lafont J; Thibout H; Dubois C; Laurent M; Martinerie C
Cell Commun Adhes; 2005; 12(1-2):41-57. PubMed ID: 16371345
[TBL] [Abstract][Full Text] [Related]
31. Focal adhesion kinase/Src suppresses early chondrogenesis: central role of CCN2.
Pala D; Kapoor M; Woods A; Kennedy L; Liu S; Chen S; Bursell L; Lyons KM; Carter DE; Beier F; Leask A
J Biol Chem; 2008 Apr; 283(14):9239-47. PubMed ID: 18276598
[TBL] [Abstract][Full Text] [Related]
32. The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.
Zuo GW; Kohls CD; He BC; Chen L; Zhang W; Shi Q; Zhang BQ; Kang Q; Luo J; Luo X; Wagner ER; Kim SH; Restegar F; Haydon RC; Deng ZL; Luu HH; He TC; Luo Q
Histol Histopathol; 2010 Jun; 25(6):795-806. PubMed ID: 20376786
[TBL] [Abstract][Full Text] [Related]
33. The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway.
Sakamoto K; Yamaguchi S; Ando R; Miyawaki A; Kabasawa Y; Takagi M; Li CL; Perbal B; Katsube K
J Biol Chem; 2002 Aug; 277(33):29399-405. PubMed ID: 12050162
[TBL] [Abstract][Full Text] [Related]
34. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
[TBL] [Abstract][Full Text] [Related]
35. Structural basis and therapeutic implication of the interaction of CCN proteins with glycoconjugates.
Desnoyers L
Curr Pharm Des; 2004; 10(31):3913-28. PubMed ID: 15579080
[TBL] [Abstract][Full Text] [Related]
36. Connective tissue growth factor: what's in a name?
Moussad EE; Brigstock DR
Mol Genet Metab; 2000; 71(1-2):276-92. PubMed ID: 11001822
[TBL] [Abstract][Full Text] [Related]
37. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
38. Expression and regulation of CCN genes in murine osteoblasts.
Parisi MS; Gazzerro E; Rydziel S; Canalis E
Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
[TBL] [Abstract][Full Text] [Related]
39. Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).
Li J; Ye L; Owen S; Weeks HP; Zhang Z; Jiang WG
Int J Mol Med; 2015 Dec; 36(6):1451-63. PubMed ID: 26498181
[TBL] [Abstract][Full Text] [Related]
40. The circulating proangiogenic factors CYR61 (CCN1) and NOV (CCN3) are significantly decreased in placentae and sera of preeclamptic patients.
Gellhaus A; Schmidt M; Dunk C; Lye SJ; Winterhager E
Reprod Sci; 2007 Dec; 14(8 Suppl):46-52. PubMed ID: 18089610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
